Nucleosyn, established in 2006, is a manufacturer specializing in the development of compounds derived from organic chemistry for applications in genomics, bio-analysis, vaccines, and diagnostics. As the French innovation and R&D subsidiary of the Biosolve Group, Nucleosyn offers a wide array of products including monomers for DNA and RNA synthesis, synthetic lipids for vaccine vectorization/transfection, and stable isotope-labeled molecules for biomarker quantification via mass spectrometry or nuclear magnetic resonance. The company's expertise lies in custom synthesis, addressing the needs of both private sector clients in the chemical, pharmaceutical, cosmetics, and biotechnology industries, as well as public institutions such as hospitals and academic research organizations.

Biosynth GmbH is a manufacturer and service provider specializing in bioconjugation and half-life extension through chemical modification, alongside the synthesis of polymers for drug delivery. Founded in 2003, the company offers high-quality customized services that include feasibility studies, up-scaling, process development, and the development and validation of analytical methods. Biosynth GmbH provides pilot GMP production of bioconjugates and functionalized polymers used as excipients in drug formulation. The company has developed innovative technologies such as multiplexing technologies for constructing homo- and heteromultimeric conjugates (celaSTAR and PaSmax®) and celaCLICK, a surface coating technology. Catering to large and medium-sized pharmaceutical, biotech, biosimilar, and diagnostic companies globally, Biosynth GmbH combines extensive chemical and biotechnological expertise to offer advanced technologies and contract development services focused on optimizing polymer-based conjugations, formulations, and drug manufacturing processes.

Key Organics is a leading UK-based Contract Research Organization (CRO) specializing in synthetic organic chemistry with over 32 years of experience. The company offers bespoke chemistry solutions, including custom synthesis of compounds and long-term FTE projects, to support discovery and development needs in the life sciences industries. Key Organics boasts an extensive product portfolio with proprietary access to over 145,000 intermediates, fragments, biochemicals, and building blocks, all available in high purity and ready for same-day dispatch. The company provides a variety of consultancy services tailored to specific client needs and covers areas such as heterocyclic chemistry, asymmetric synthesis, and integrated analytical services. As part of the Tennants Group, Key Organics is committed to expanding its services and products, especially in the US market.

Nucleus Biologics is a biotechnology company based in San Diego, specializing in the manufacture of bespoke media formulations and supplements for the cell and gene therapy market. The company offers a comprehensive ecosystem of innovative products and services to simplify and expedite custom cell culture media design, ensuring compliance with GMP manufacturing under an ISO 13485:2016-certified quality system. Their offerings include digital tools, off-the-shelf supplements and reagents, as well as cutting-edge instrumentation for enhancing the development process and reducing waste and greenhouse gas emissions. Nucleus Biologics focuses on providing solutions that drive reproducibility and efficiency in cell culture, aiming to disrupt traditional practices in the industry while empowering scientists and clinicians with educational resources and competitive advantages for commercialization.

NobleBio is a manufacturer of microbial-based products specializing in strain isolation, screening, and fermentation. The company offers comprehensive technical and marketing support, including label review, technical data sheet assistance, and regulatory guidance, ensuring that products meet rigorous standards. NobleBio collaborates with clients to develop microorganisms that address environmental, agricultural, and commercial challenges while promoting natural alternatives to chemicals. The company's core mission is to foster a greener world through nature-based solutions.

Biolegio is a manufacturer specializing in the synthesis of custom oligonucleotides for life science applications. The company produces a wide range of products including primers and probes specifically designed for RT-qPCR testing, facilitating significant advancements in COVID-19 diagnostics. With over 20 years of expertise, Biolegio serves customers globally, including universities and hospitals, by providing oligos for genetic research, diagnostic device development, and other biotechnology applications. The company’s offerings include MGB replacement probes, MPLA, long oligos, standard oligos, real-time PCR probes, as well as various purifications, plate synthesis, and modifications, supporting a diverse array of health care and research initiatives.